We will be attending DCAT week in NYC from March 23-26, 2020.
Our drug development and commercial manufacturing experts, Tobi Williams, Nabil Lally and Jack Milligan, and Chief Scientific Officer, Peter Scholes will be on hand to meet with you to discuss your small molecule drug program's needs.
Learn about Quotient's extensive capabilities to overcome solubility issues with robust technologies like Spray Drying and Hot Melt Extrusion and our high potency handling capabilities in both the US and UK.
If you'd like to schedule a meeting with our experts during the event, click here.
We will also be holding a seminar at DCAT on Tuesday, March 24th from 11am to 1pm at Smith & Wollensky Steakhouse entitled:Assessing the Financial Impact of Translational Pharmaceutics - A Platform for Accelerating Drug Development.
For more information and to register click here.